Bollywood Icon Vindu Dara Singh Invests in Abhay HealthTech

Abhay HealthTech Pvt. Ltd. (AHPL), a company operating in the Indian OTC healthcare market, has raised an undisclosed amount in funding from Bollywood icon Vindu Dara Singh.

Singh, who is the son of the legendary wrestler and actor Dara Singh, has chosen to invest in AHPL due to its innovative approach to healthcare and rapid growth in the market.

"I am excited to be a part of Abhay HealthTech's journey as it leads the way in transforming healthcare. Their commitment to innovation, quality, and customer satisfaction aligns perfectly with my values. This investment is not just about financial support; it is about a shared belief in a healthier future for all," said Vindu Dara Singh.

What does Abhay HealthTech do?

Abhay HealthTech Pvt. Ltd. is a dynamic healthcare conglomerate that has quickly established itself in the Indian market with a diverse portfolio of technology-enabled services and products.

Founded in 2023 by Apurv Abhay Modi and Sougat Chatterjee, the company offers a wide range of consumer health products, OTC medicines, home diagnostics, fast testing kits, and ayurvedic well-being items.

Additionally, they provide hospital management ERP, CRM, hospital management consultancy, and healthcare business advisory services. The company aims to revolutionize healthcare with cutting-edge solutions that meet consumers' evolving needs.

Leadership comments

“We are thrilled to welcome Vindu Dara Singh as an investor in Abhay Health. Our focus remains on delivering high-quality, innovative healthcare products that enhance the well-being of our customers. This partnership will accelerate our efforts to bring advanced healthcare solutions to a wider audience," said Sougat Chatterjee, Co-founder and CEO.

The company has rapidly expanded into key markets across North, East, and West India, particularly in the personal hygiene category, contributing to its swift growth.